Elizabeth D. Fixman

2.6k total citations
41 papers, 2.2k citations indexed

About

Elizabeth D. Fixman is a scholar working on Physiology, Immunology and Molecular Biology. According to data from OpenAlex, Elizabeth D. Fixman has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 15 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Elizabeth D. Fixman's work include Asthma and respiratory diseases (17 papers), IL-33, ST2, and ILC Pathways (11 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Elizabeth D. Fixman is often cited by papers focused on Asthma and respiratory diseases (17 papers), IL-33, ST2, and ILC Pathways (11 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Elizabeth D. Fixman collaborates with scholars based in Canada, United States and United Kingdom. Elizabeth D. Fixman's co-authors include S. Diane Hayward, Gary S. Hayward, James G. Martin, Morag Park, Monica A. Naujokas, Tanya M. Fournier, Darren M. Kamikura, Jichuan Shan, Alastair G. Stewart and Qutayba Hamid and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Elizabeth D. Fixman

40 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth D. Fixman Canada	23	786	659	559	557	417	41	2.2k
Andrew C. Melton United States	17	435 0.6×	193 0.3×	388 0.7×	936 1.7×	168 0.4×	30	1.7k
Keiichi Tamai Japan	24	1.3k 1.6×	355 0.5×	120 0.2×	260 0.5×	421 1.0×	63	2.2k
Claire Piquet‐Pellorce France	25	731 0.9×	290 0.4×	106 0.2×	1.1k 1.9×	431 1.0×	58	2.1k
Carol Anne Ogden United States	16	795 1.0×	345 0.5×	560 1.0×	2.3k 4.1×	223 0.5×	20	3.2k
Floyd E. Fox United States	23	711 0.9×	807 1.2×	64 0.1×	492 0.9×	152 0.4×	58	2.0k
Angela Costantino Italy	23	1.8k 2.3×	663 1.0×	123 0.2×	158 0.3×	652 1.6×	61	3.2k
Shamith Samarajiwa United Kingdom	17	907 1.2×	549 0.8×	316 0.6×	807 1.4×	393 0.9×	24	2.1k
Farshid N. Rouhani United States	24	1.0k 1.3×	586 0.9×	180 0.3×	603 1.1×	227 0.5×	39	2.3k
Takashi Tanaka Japan	10	606 0.8×	679 1.0×	303 0.5×	1.2k 2.2×	85 0.2×	11	2.1k
Kazuhiko Yamamura Japan	23	595 0.8×	196 0.3×	243 0.4×	475 0.9×	249 0.6×	52	1.7k

Countries citing papers authored by Elizabeth D. Fixman

Since Specialization

Citations

This map shows the geographic impact of Elizabeth D. Fixman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth D. Fixman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth D. Fixman more than expected).

Fields of papers citing papers by Elizabeth D. Fixman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth D. Fixman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth D. Fixman. The network helps show where Elizabeth D. Fixman may publish in the future.

Co-authorship network of co-authors of Elizabeth D. Fixman

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth D. Fixman. A scholar is included among the top collaborators of Elizabeth D. Fixman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth D. Fixman. Elizabeth D. Fixman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shan, Jichuan, et al.. (2023). Female-specific enhancement of eosinophil recruitment and activation in a type 2 innate inflammation model in the lung. Clinical & Experimental Immunology. 216(1). 13–24. 6 indexed citations

Shan, Jichuan, et al.. (2022). STAT6-IP–Dependent Disruption of IL-33–Mediated ILC2 Expansion and Type 2 Innate Immunity in the Murine Lung. The Journal of Immunology. 209(11). 2192–2202. 4 indexed citations

Traboulsi, Hussein, Angela Rico de Souza, Benoît Allard, et al.. (2021). Differential Regulation of the Asthmatic Phenotype by the Aryl Hydrocarbon Receptor. Frontiers in Physiology. 12. 720196–720196. 5 indexed citations

Gomord, Véronique, Anne‐Catherine Fitchette, Elizabeth D. Fixman, et al.. (2020). Design, production and immunomodulatory potency of a novel allergen bioparticle. PLoS ONE. 15(12). e0242867–e0242867. 12 indexed citations

Shan, Jichuan, et al.. (2019). Sex Differences in IL-33-Induced STAT6-Dependent Type 2 Airway Inflammation. Frontiers in Immunology. 10. 859–859. 19 indexed citations

Lee, Soojin, et al.. (2018). STAT6 inhibitory peptide reduces dendritic cell migration to the lymph nodes to control Th2 adaptive immunity in the mouse lung. European Journal of Immunology. 49(1). 157–169. 14 indexed citations

Ward, Brian J., et al.. (2018). Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma. Frontiers in Immunology. 9. 1249–1249. 42 indexed citations

Xue, Di, Marieme Dembele, Amir Hossein Massoud, et al.. (2016). Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138+ Plasma Cells. The Journal of Immunology. 198(1). 71–81. 18 indexed citations

Shan, Jichuan, et al.. (2016). STAT6 inhibitory peptide given during RSV infection of neonatal mice reduces exacerbated airway responses upon adult reinfection. Journal of Leukocyte Biology. 101(2). 519–529. 16 indexed citations

10.

Nakada, Emily M., et al.. (2014). Adjuvant-dependent regulation of interleukin-17 expressing γδ T cells and inhibition of Th2 responses in allergic airways disease. Respiratory Research. 15(1). 90–90. 33 indexed citations

11.

Fixman, Elizabeth D., et al.. (2014). Inhibition of STAT6 during vaccination with formalin‐inactivated RSV prevents induction of Th2‐cell‐biased airway disease. European Journal of Immunology. 44(8). 2349–2359. 5 indexed citations

12.

Shan, Jichuan, et al.. (2013). Dose-Dependent Effects of IL-17 on IL-13–Induced Airway Inflammatory Responses and Airway Hyperresponsiveness. The Journal of Immunology. 190(8). 3859–3868. 55 indexed citations

13.

Wang, Yifan, Yunguo Li, Jichuan Shan, Elizabeth D. Fixman, & Christine McCusker. (2011). Effective treatment of experimental ragweed‐induced asthma with STAT‐6‐IP, a topically delivered cell‐penetrating peptide. Clinical & Experimental Allergy. 41(11). 1622–1630. 26 indexed citations

14.

Valderrama-Carvajal, Héctor, et al.. (2006). Endothelin-1 Regulates Proliferative Responses, both alone and Synergistically with PDGF, in Rat Tracheal Smooth Muscle Cells. Cellular Physiology and Biochemistry. 17(1-2). 37–46. 34 indexed citations

15.

Ramos‐Barbón, David, et al.. (2006). Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration. Journal of Immunological Methods. 314(1-2). 80–89. 2 indexed citations

16.

Ramos‐Barbón, David, John F. Presley, Qutayba Hamid, Elizabeth D. Fixman, & James G. Martin. (2005). Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. Journal of Clinical Investigation. 115(6). 1580–1589. 109 indexed citations

17.

Fixman, Elizabeth D., et al.. (2001). Src-family tyrosine kinases, phosphoinositide 3-kinase and Gab1 regulate extracellular signal-regulated kinase 1 activation induced by the type A endothelin-1 G-protein-coupled receptor. Biochemical Journal. 360(1). 77–77. 28 indexed citations

18.

Fixman, Elizabeth D., Marina Holgado-Madruga, Linh T. Nguyen, et al.. (1997). Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1. Journal of Biological Chemistry. 272(32). 20167–20172. 104 indexed citations

19.

Fixman, Elizabeth D., Tanya M. Fournier, Darren M. Kamikura, Monica A. Naujokas, & Morag Park. (1996). Pathways Downstream of Shc and Grb2 Are Required for Cell Transformation by the Tpr-Met Oncoprotein. Journal of Biological Chemistry. 271(22). 13116–13122. 108 indexed citations

20.

Zhu, Hongbo, et al.. (1994). Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis.. Journal of Biological Chemistry. 269(47). 29943–29948. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact